Stock Events

Stock Events

BB Biotech

€48.80

277

+€0.90+1.88% Friday 15:32

Statistics

Day High

49

Day Low

48.1

52W High

50.7

52W Low

44.95

Volume

-

Avg. Volume

-

Mkt Cap

0

P/E Ratio

-

Dividend Yield

5.05%

Dividend

2.46

Upcoming

Dividend Payment

Dividend Payment

Dividends

5.05%Dividend Yield

Mar 26

€2.46

Mar 25

€1.88

Mar 24

€2.05

Mar 23

€2.88

Mar 22

€3.74

10Y Growth

1.8%

5Y Growth

-5.48%

3Y Growth

-5.08%

1Y Growth

30.84%

Earnings

24JulExpected

Q3 2024

Next

-3.14

-2.8

-2.47

-2.14

Expected EPS

N/A

Actual EPS

N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BION.VI. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

iShares Biotechnology

iShares Biotechnology ETF, competes by investing in biotech companies, similar to BB Biotech's investment strategy.

State Street SPDR S&P Biotech

SPDR S&P Biotech ETF, competes as it also focuses on biotechnology investments, offering a similar market exposure.

First Trust NYSE Arca Biotechnology Index Fund

First Trust NYSE Arca Biotechnology Index Fund, a direct competitor through its biotech-focused investment portfolio.

ARK Genomic Revolution

ARK Genomic Revolution ETF, competes by investing in the genomic industry, overlapping with BB Biotech's investment interests.

VanEck Vectors Biotech ETF, offers exposure to biotech firms, directly competing with BB Biotech's investment focus.

Principal Healthcare Innovators

Principal Healthcare Innovators Index ETF, competes by focusing on healthcare innovation, including biotech, similar to BB Biotech.

Invesco Biotechnology & Genome

Invesco Dynamic Biotechnology & Genome ETF, competes through its focus on biotech and genomic revolution, akin to BB Biotech's strategy.

ALPS Medical Breakthroughs

ALPS Medical Breakthroughs ETF, competes by investing in small- and mid-cap biotech companies, a market segment also targeted by BB Biotech.

Direxion Daily S&P Biotech Bull 3X

Direxion Daily S&P Biotech Bull 3X Shares, competes as a leveraged ETF focusing on biotech, offering aggressive exposure similar to BB Biotech's sector focus.

Direxion Daily S&P Biotech Bear 3X

Direxion Daily S&P Biotech Bear 3X Shares, competes by offering inverse exposure to the biotech sector, providing an alternative strategy to BB Biotech's investments.

About

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.

Show more...

CEO

ISIN

CH0038389992

Listings

0 Comments

Share your thoughts

FAQ

What is BB Biotech stock price today?▼

The current price of BION.VI is €48.80 EUR — it has increased by +1.88% in the past 24 hours. Watch BB Biotech stock price performance more closely on the chart.

What is BB Biotech stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange BB Biotech stocks are traded under the ticker BION.VI.

When is the next BB Biotech earnings date?▼

BB Biotech is going to release the next earnings report on July 24, 2026.

What were BB Biotech earnings last quarter?▼

BION.VI earnings for the last quarter are -3.14 EUR per share, whereas the estimation was N/A EUR resulting in a N/A surprise. The estimated earnings for the next quarter are N/A EUR per share.

Does BB Biotech pay dividends?▼

Yes, BION.VI dividends are paid annual. The last dividend per share was 2.46 EUR. As of today, Dividend Yield (FWD)% is 5.05%.

In which sector is BB Biotech located?▼

BB Biotech operates in the Other sector.

When did BB Biotech complete a stock split?▼

BB Biotech has not had any recent stock splits.